TGFB1 and COVID-19: Accordingly, plasma from adult COVID-19 patients, but not that from elderly patients, significantly reduced IFN-γ production by healthy donor NK cells and anti-TGF-β blocking antibody reverted this inhibitory effect, thus demonstrating a crucial role of this cytokine in these regulatory mechanisms (Figure 10E).